In last trading session, Lipocine Inc (NASDAQ:LPCN) saw 0.45 million shares changing hands with its beta currently measuring 1.39. Company’s recent per share price level of $3.99 trading at $0.26 or 6.97% at ring of the bell on the day assigns it a market valuation of $21.35M. That closing price of LPCN’s stock is at a discount of -195.49% from its 52-week high price of $11.79 and is indicating a premium of 32.83% from its 52-week low price of $2.68. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 44980.0 shares which gives us an average trading volume of 17.46K if we extend that period to 3-months.
Lipocine Inc (NASDAQ:LPCN) trade information
Upright in the green during last session for gaining 6.97%, in the last five days LPCN remained trading in the green while hitting it’s week-highest on Friday, 05/16/25 when the stock touched $3.99 price level, adding 5.67% to its value on the day. Lipocine Inc’s shares saw a change of -18.24% in year-to-date performance and have moved 21.83% in past 5-day. Lipocine Inc (NASDAQ:LPCN) showed a performance of 32.56% in past 30-days. Number of shares sold short was 70640.0 shares which calculate 6.28 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 10 to the stock, which implies a rise of 60.1% to its current value. Analysts have been projecting 10 as a low price target for the stock while placing it at a high target of 10. It follows that stock’s current price would drop -150.63% in reaching the projected high whereas dropping to the targeted low would mean a loss of -150.63% for stock’s current value.
Lipocine Inc (LPCN) estimates and forecasts
This year revenue growth is estimated to fall -89.25% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 358k for the same. And 1 analysts are in estimates of company making revenue of 370k in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 82.03% during past 5 years.
Lipocine Inc (NASDAQ:LPCN)’s Major holders
Insiders are in possession of 2.95% of company’s total shares while institution are holding 9.73 percent of that, with stock having share float percentage of 10.03%. Investors also watch the number of corporate investors in a company very closely, which is 9.73% institutions for Lipocine Inc that are currently holding shares of the company.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 141.08 shares of worth $0.56 million or 2.64% of the total outstanding shares. The later fund manager was in possession of 74.28 shares on Dec 31, 2024 , making its stake of worth around $0.3 million in the company or a holder of 1.39% of company’s stock.
